v3.25.2
Segment Information
 12 Months Ended
Apr. 30, 2025
Segment Reporting [Abstract]  
Segment Information

Note 9 - Segment Information

Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the CODM in deciding how to allocate resources and in assessing performance. The Company has determined that its CODM is its Chief Executive Officer.

Management and the CODM view the Company’s operations and manage its business in one operating segment, which is the business of identifying, developing and commercializing products and AI-ECG solutions in the cardiovascular diagnostic technology field. The CODM uses operating expenses to measure performance against progress in its clinical trials and its product development. The Company's CODM reviews and evaluates the total net loss for purposes of assessing performance, making operating decisions, allocating resources, and planning and forecasting for future periods.

The following table summarizes the segment's financial information including the Company's significant segment expenses:

 

 

April 30,

 

 

April 30,

 

 

 

2025

 

 

2024

 

 

 

 

 

 

 

 

Gross Margin

 

$

2,470

 

 

$

12,519

 

Segment operating expenses:

 

 

 

 

 

 

Clinical and regulatory

 

 

756,189

 

 

 

721,428

 

Research and development

 

 

3,456,312

 

 

 

1,994,173

 

Sales and marketing

 

 

350,167

 

 

 

539,682

 

Operations

 

 

173,604

 

 

 

162,953

 

General and administrative

 

 

3,618,769

 

 

 

2,900,053

 

Loss from operations

 

 

(8,352,571

)

 

 

(6,305,770

)

Interest expense

 

 

500,453

 

 

 

354,080

 

Other income

 

 

(87,795

)

 

 

(54,642

)

Total other expense

 

 

412,658

 

 

 

299,438

 

Net loss

 

$

(8,765,229

)

 

$

(6,605,208

)